News & Press

Recent News

United Orthopedic Corporation Wins Bronze at 21st Annual Medical Design Excellence Awards

June 17, 2019

  1. U2 Knee AiO™ Block and MDT™ Recognized as Significant Achievements Among Implant and Tissue-Replacement Products

California, June 12, 2019 - United Orthopedic Corporation (UNITED), a leading international designer, manufacturer and distributor of innovative orthopedic implants and instruments, today announced that its U2 Knee AiO™ Block and Modular Disposable TrialTM (MDT) have earned UNITED a Bronze award in the 21st Annual Medical Design Excellence Awards (MDEA). The U2 Knee AiO Block and MDT were recognized as significant achievements in the "Implant and Tissue-Replacement Product" category.

“On behalf of the design and engineering team, we are honored to have had our U2 Knee AiO Block and MDT selected by the MDEA for this prestigious award,” said Jason Lin, Chairman and CEO of United Orthopedic Corporation. “As innovators striving to create a more efficient and precise environment within operating rooms across the orthopedic space, we take great pride in being recognized for our work and in continuing to improve the total knee replacement experience for surgeons and patients alike.”

The U2 Knee AiO Block and MDT are used to assist orthopedic surgeons in increasing precision and efficiency for total knee arthroplasty (TKA) operations. The AiO Block is user-friendly instrument which integrates the femoral sizer with the A/P resection guide and enables surgeons to properly position the U2 Knee femoral components anteriorly and posteriorly. It can decrease the possibility of anterior cortex notching and help to prevent mal-rotation. The MDT allows for modular convenience with its intra-operative flexibility of converting from a cruciate retaining trial to a posterior stabilizing version during the surgery. Because of its single-use design it can improve patient safety by potentially reducing the risk of infection. The combination of U2 Knee AiO Block and MDT allows for the removal of 163 instruments from the sterile field and reduces the total surgical tray count from 6 to 1.5 trays. This reduction has great potential to generate significant cost savings.

The MDEA program honors innovative advances in medical product design and engineering. The awards recognize winners based on excellence based upon the following criteria: benefits to overall healthcare, design and engineering innovation, functional innovation, benefit to patients, and market differentiation within the competitive landscape.

# # #

About Medical Design Excellence Awards
The MDEA program is presented by Informa’s Advanced Manufacturing portfolio, the leading B-to-B event producer, publisher, and digital media business for the world's $3 trillion advanced, technology-based manufacturing industry, and by Medical Device and Diagnostic Industry (MD+DI), the industry’s central source for late breaking news, information, and business intelligence. For more information about the Medical Design Excellence Awards—including additional details about the manufacturers and suppliers that created the 2019 MDEA-winning products—visit the MDEA website at ww.MDEAwards.com or e-mail: mdea@ubm.com.

About United Orthopedic Corporation
United Orthopedic Corporation is a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instrument sets. The company offers clinically proven solutions used in primary and revision total hip/knee replacement, in addition to oncology applications. The company has implemented and maintains Quality Management Systems compliant with ISO 13485, FDA and CE requirements. To learn more visit www.uocusa.com.

# # #

Media Contact:
Tiffany Lin
tiffany.lin@uocusa.com
Tel: +1 949-328-3366

THINK Surgical and United Orthopedic Corporation Announce Collaboration to Deliver Enhanced Precision and Pursue Reproducible Outcomes in Total Knee Replacements

March 13, 2019

  1. Announcement Made at AAOS 2019 Annual Meeting

California, March 13, 2019 - THINK Surgical, Inc. (THINK), an advanced robotic technology company and marketer of the first active robotic surgical system for orthopedic surgery, and United Orthopedic Corporation (UNITED), a leading international designer, manufacturer and distributor of innovative orthopedic implants and instruments, today announced a collaboration aimed at enabling enhanced precision and providing a better fit in total knee replacements. The companies made the announcement at the American Academy of Orthopaedic Surgeons (AAOS) 2019 annual meeting, taking place from March 12-16, 2019 in Las Vegas, NV.

The collaboration will focus on harnessing the advantages of each company’s current pioneering technology: THINK’s Active Robotic System and UNITED’s U2TM Knee System. Joint marketing will incorporate each system into a packaged offering for orthopedic surgeons and allow these combined technologies to be delivered on a global scale.

"We are excited about what this collaboration and complete package offering will bring to orthopedic markets worldwide. By combining THINK’s Active Robotic System and UNITED’s U2TM Knee System, we believe we will be able to offer unparalleled precision and have the potential to minimize opportunities for error, all while helping to ensure procedures are executed as close to their design as possible," said Jason Lin, Chairman and CEO of United Orthopedic Corporation. "By working together, in time we may be able to offer a solution that reduces healthcare costs and improves outcomes for total knee replacement patients."

THINK’s Active Robotic System combines two exclusive innovations to produce a revolutionary piece of technology. The system consists of a 3D pre-surgical planning workstation and the Active Robot, a computer assisted tool. These technologies provide an option for total joint replacement surgery that ensures surgical plans can be carried out precisely as defined. The system’s use in total knee arthroplasty is the subject of a TKA IDE study, which has completed patient enrollment with FDA clearance anticipated in 2019. Outside of the U.S., the Active Robotic System core technology has been used in thousands of total hip and knee replacements worldwide.

As part of the collaboration, UNITED will serve as THINK’s exclusive distributor in Taiwan and designate Taiwan as a center of excellence for their combined platforms. In addition to offering a total “one-stop” solution to precision total joint arthroplasty for surgeons, the companies plan to explore cooperative development of implants specifically designed for active robotic surgeries in order to provide an improved alternative to currently available total joint replacement procedures.

“Combined with UNITED’s quarter-century reputation as a reliable manufacturer in the medical device space, we believe that THINK’s expertise in robotic technologies will allow us to potentially offer surgeons a more precise experience in total joint replacement surgery,” said John Hahn, THINK Surgical’s CEO and President.

The U2TM Knee System has been commercially available in the United States since 2006, and has been implanted in more than 140,000 surgical cases in 39 countries. The U2TM Knee System provides surgeons with a simple surgical procedure and reduces the number of trays required from 6 to 1.5.

UNITED (booth #3255) and THINK (booth #3834) will both exhibit at the AAOS annual meeting from March 13-15, 2019. THINK will showcase UNITED’s U2TM Knee System and UNITED will display THINK’s Active Robotic System.

# # #

About THINK Surgical, Inc.
THINK Surgical, Inc. is committed to the future of orthopedic surgery and to improving patient care through the development of leading-edge precision technology. THINK Surgical develops, manufactures and markets the first active robotic surgical system for orthopedic surgery and maintains an open implant policy, allowing surgeons maximum choice for their patients. For more information, visit www.THINKSurgical.com.

About United Orthopedic Corporation
United Orthopedic Corporation is a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instrument sets.The company offers clinically proven solutions used in primary and revision total hip/knee replacement in addition to oncology applications. The company has implemented and maintains Quality Management Systems compliant with ISO 13485, FDA and CE requirements. To learn more visit www.uocusa.com.

Media Contact:
Tiffany Lin
tiffany.lin@uocusa.com
Tel: +1 949-328-3366

United Orthopedic Corporation Announces FDA Clearance for Vitamin E Highly Cross-Linked Polyethylene Hip Liner

November 27, 2018

  1. E-XPETM Designed to Provide Wear Resistance with Reduced Risk of Oxidation is Now Available in Both Knee Inserts and Hip Liners

IRVINE, Calif., November 27, 2018 – United Orthopedic Corporation, a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments, today announced that the U.S. Food and Drug Administration has cleared its vitamin E highly cross-linked polyethylene (E-XPETM) hip liner. The E-XPETM is the new generation of highly cross-linked polyethylene blended with vitamin E to enhance wear resistance without compromising oxidative stability and mechanical properties.

“Oxidation continues to be a concern for surgeons. Over time, wear of conventional polyethylene can generate debris in the joint, triggering local inflammation that results in bone loss which is one of the biggest causes of late-term failure in hip and knee replacements,” said Calvin Lin, President of United Orthopedic Corporation USA. “Clearance of our E-XPETM, a vitamin E highly cross-linked polyethylene, provides surgeons with an alternative implant for their patient. Our vertically integrated manufacturing process affords us the flexibility to design, manufacture and distribute implants or instruments that address many of the most significant needs in the orthopedic industry.”

Vitamin E is an effective biological antioxidant which helps prevent the oxidative degradation of cell membrane phospholipids. When added to ultra-high molecular weight polyethylene (“UHMWPE”), vitamin E performs a similar role by helping to prevent oxidation of the polyethylene chains.1 Vitamin E -stabilized UHMWPE is a biocompatible material with good mechanical, wear, and oxidative proprieties. Results from accelerated aging tests show that E-XPETM inserts and liners exhibited a 60 percent and 75 percent reduction, respectively, in gravimetric wear2. E-XPETM material provides greater strength in comparison to re-melted highly crosslinked polyethylene while maintaining oxidation resistance as demonstrated in mechanical tests.

An estimated 4.7 million Americans have undergone total knee arthroplasty (“TKA”) and 2.5 million have undergone total hip arthroplasty (“THA”).The prevalence of THA rises to nearly 6 percent by 80 years of age. The prevalence of TKA rises to nearly 10 percent by 80 years of age.3

# # #

About United Orthopedic Corporation
United Orthopedic Corporation is a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instrument sets.

The company offers clinically proven solutions used in primary and revision total hip/knee replacement in addition to oncology applications. The company has implemented and maintains Quality Management Systems compliant with ISO 13485, FDA and CE requirements. To learn more visit www.uocusa.com.

Media Contact:
Tiffany Lin
tiffany.lin@uocusa.com
Tel: +1 949-328-3366

# # #

_____________________________

1 Gigante A, Bottegoni C, Ragone V, Banci L. Effectiveness of Vitamin-E-Doped Polyethylene in Joint Replacement: A Literature Review. J Funct Biomater 2015; 6(3):889-900.

2 Chang TW, Cheng YW, Lu CK, Liau JJ. Is Highly Cross Linked UHMWPE Blended with Vitamin E a Viable Reduction Wear in TKA? Presented at Orthopaedic Research Society, 2017, San Diego, CA.

3 Maradit Kremers H, Larson DR, Crowson CS, Kremers WK, Washington RE, Steiner CA et al. Prevalence of Total Hip and Knee Replacement in the United States. J Bone Joint Surg Am 2015; 97(17):1386-97.

United Orthopedic Corporation Announces UTS™ Hip Stem and an Extension of its U-Motion II™ Acetabular System Are Now Available

November 1, 2018

United Orthopedic Corporation Announces UTS™ Hip Stem and an Extension of its U-Motion II™ Acetabular System Are Now Available

IRVINE, Calif., November 1, 2018 – United Orthopedic Corporation, a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments, today announced that the UTS™ (United Tri-tapered Short Stem) hip stem and an extension of the U-Motion II™ Acetabular System are now available to surgeons in the U.S.

"The UTS hip stem and U-Motion II extension reflect our commitment to addressing some of the challenges in today’s hip replacement market – reducing dislocations and providing solutions that support rapid recovery from surgery,” said Calvin Lin, President of United Orthopedic Corporation USA. "Since the launch of these products at this year’s American Academy of Orthopaedic Surgeons Annual Meeting, we have received positive feedback from orthopedic surgeons, citing easier insertion of the hip stem, greater range of motion and improved stability."

The UTS hip stem is a tapered wedge short stem suitable for less invasive primary hip replacement. It is designed for easier insertion through small incisions and requires simpler femoral preparation, enabling rapid recovery. Shorter stems preserve bone, which allows for more favorable conditions in future revisions.1 The UTS hip stem is available in 14 refined proximal sizes. Its features include standard and high offset options for restoring joint biomechanics, and a reduced lateral shoulder designed to conserve bone in the greater trochanter.

"The shortened stem length and plasma coating coupled with the unique shape and properties of the UTS stem afford greater stability at the time of implantation." said Richard Steinfeld, M.D., a practicing orthopedic surgeon from Orthopaedic Center of Vero Beach, Fla. "This provides for greater bone conservation and affords patients the ability to fully weight bear immediately following their surgical procedure."

"The UTS hip stem offers some unique advantages over other hip stems on the market. The proximal porous ingrowth surface and tapered design allows for early weight bearing while preventing subsidence. Multiple offset options are available, allowing fine tuning of the soft tissue balance and stability during surgery." said Ronald Hillock, M.D., an orthopedic surgeon at the Nevada Orthopedic & Spine Center, in Las Vegas, Nev. "The instruments are well thought out and streamlined. I have been pleased with my initial UTS experience."

The extension of the U-Motion II Acetabular System for total hip replacement surgery includes a 50mm acetabular cup and cup liner, which is compatible with the 36mm BIOLOX® delta ceramic and CoCrMo metal femoral heads. The 36mm femoral head with the new U-Motion II 50mm Acetabular cup is designed to provide patients a greater range of motion2, increase jumping distance, improve stability and lower the risk of dislocation.

The demand for primary total hip arthroplasties is estimated to grow by 174% to 572,000 by 2030, while the demand for hip revisions is projected to double by 2026.3 Dislocation continues to be one of the most common causes of failure after primary and revision total hip arthroplasty. Clinical studies show large femoral heads decrease the incidence of dislocation after total hip arthroplasty.4

# # #

About United Orthopedic Corporation
United Orthopedic Corporation (UOC) is a leading international designer, manufacturer, and distributor of innovative, regulatory compliant orthopedic implants and instrument sets used by surgeons around the globe. Our offering includes a flexible range of clinically proven solutions used to perform total hip/knee replacements and revisions, plus clinical education, service and support for surgeons and hospital staff. UOC operates Quality Management Systems (QMS) that comply with ISO 9001/13485, FDA, and CE requirements. For more information about United Orthopedic Corporation, visit www.uocusa.com.

Media Contact:
Tiffany Lin
tiffany.lin@uocusa.com
Tel: +1 949-328-3366

# # #

1 Molli RG,et al. A Short Tapered Stem Reduces Intraoperative Complications in Primary Total Hip Arthroplasty. Clin Orthop Relat Res. 2012 Feb;470(2):450-61.

2 Guyen O. Constrained liners, dual mobility or large diameter heads to avoid dislocation in THA. EFORT Open Reviews. 2016;1(5):197-204. doi:10.1302/2058-5241.1.000054.

3Kurtz, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5.

4Howie, et al. Large femoral heads decrease the incidence of dislocation after total hip arthroplasty: a randomized controlled trial. J Bone Joint Surg Am. 2012 Jun 20;94(12):1095-102. doi: 10.2106/JBJS.K.00570.

United Orthopedic Corporation Launches UTSTM Hip Stem and an Extension of its U-Motion IITM Acetabular System at the American Academy of Orthopaedic Surgeons Annual Meeting

March 7, 2018

United Orthopedic Corporation Launches UTSTM Hip Stem and an Extension of its U-Motion IITM Acetabular System at the American Academy of Orthopaedic Surgeons Annual Meeting

IRVINE, Calif., March 7, 2018 – United Orthopedic Corporation, a leading international designer, manufacturer and distributor of innovative orthopedic implants and instruments, announced today, at the American Academy of Orthopaedic Surgeons Annual Meeting in New Orleans, the launch of the UTSTM (United Tri-tapered Short Stem) hip stem and an extension of the U-Motion IITM Acetabular System.

“We are committed to developing quality, innovative orthopedic products that improve patient outcomes and address the market’s needs,” said Calvin Lin, President of United Orthopedic Corporation USA. “Our unique vertically integrated manufacturing model has enabled us to launch two products which provide surgeons with more treatment options for total hip replacement. One is the UTSTM hip stem, which facilitates less invasive surgery and aids in rapid recovery. The other is a new cup and cup liner – an extension of the U-Motion IITM Acetabular System – which is designed to reduce the risk of dislocation following a total hip replacement.”

The UTSTM hip stem – ideal for the direct anterior approach for total hip replacement – is a tapered wedge short stem suitable for less invasive primary hip replacement surgery. It is designed for easier insertion through small incisions and requires simpler femoral preparation, enabling rapid recovery. Shorter stems preserve bone, which allows for more favorable conditions in future revisionsi. The UTSTM hip stem is available in 14 refined proximal sizes. Its features include:

  • Standard and high offset options for restoring joint biomechanics
  • Triple taper design with Titanium Plasma coating that provides initial fixation and enhances rotation stability
  • Reduced lateral shoulder designed to conserve bone in the greater trochanter

The demand for primary total hip arthroplasties is estimated to grow by 174% to 572,000 by 2030, while the demand for hip revisions is projected to double by 2026. Dislocation continues to be one of the most common causes of failure after primary and revision total hip arthroplasty. Clinical studies show large femoral heads decrease the incidence of dislocation after total hip arthroplasty.

The extension of the U-Motion IITM Acetabular System for total hip replacement surgery includes a 50mm acetabular cup and cup liner, which is compatible with the 36mm BIOLOX® delta ceramic and CoCrMo metal femoral heads. The pole thickness of the liner is 5.3mm, which is greater than ISO 21315’s requirement of 5mm to reduce the risk of breakage. The 36mm femoral head with the new U-Motion IITM 50mm Acetabular cup will provide patients a greater range of motion , increase jumping distance, improve stability and lower the risk of dislocation.

About United Orthopedic Corporation
United Orthopedic Corporation (UOC) is a leading international designer, manufacturer, and distributor of innovative, regulatory compliant orthopedic implants and instrument sets used by surgeons around the globe. UOC’s offering includes a flexible range of clinically proven solutions used to perform total hip/knee replacements and revisions, plus clinical education, service and support for surgeons and hospital staff. UOC operates Quality Management Systems (QMS) that comply with ISO 9001/13485, FDA, and CE requirements. For more information about United Orthopedic Corporation, visit www.uocusa.com.

Media Contact:
Tiffany Lin
tiffany.lin@uocusa.com
Tel: +1 949-328-3366

# # #

i Molli RG,et al. A Short Tapered Stem Reduces Intraoperative Complications in Primary Total Hip Arthroplasty. Clin Orthop Relat Res. 2012 Feb;470(2):450-61.

ii Kurtz, et al. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5.

iiiHowie, et al. Large femoral heads decrease the incidence of dislocation after total hip arthroplasty: a randomized controlled trial. J Bone Joint Surg Am. 2012 Jun 20;94(12):1095-102. doi: 10.2106/JBJS.K.00570.

ivGuyen O. Constrained liners, dual mobility or large diameter heads to avoid dislocation in THA. EFORT Open Reviews. 2016;1(5):197-204. doi:10.1302/2058-5241.1.000054.

United Orthopedic Corporation Announces First Patient Enrollment in Study of U2 Knee™ System

May 23, 2017

UNITED ORTHOPEDIC CORPORATION ANNOUNCES FIRST PATIENT ENROLLMENT IN STUDY OF U2 KNEE™ SYSTEM

Study to Evaluate Clinical Performance of the System in Primary Total Knee Arthroplasty

IRVINE, Calif., May 23, 2017 – United Orthopedic Corporation (UOC), a leading international designer, manufacturer and distributor of innovative orthopedic implants and instruments, today announced the launch of a primary total knee arthroplasty (TKA) trial. Entitled “Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U2 Knee™ System – ‘U Propel Study’,” the trial recently enrolled its first patient. This prospective, single arm, multi-center, post-market study will evaluate the short- and long-term clinical performance, and implant survivorship of the commercially available U2 Knee™ System in subjects receiving primary TKA.

“We were extremely confident with the execution and success of the first U2 Knee System replacement,” said David Cashen, MD, principal study investigator and practicing orthopedic surgeon at Coastal Orthopedics in Bradenton, Fla. “One day after surgery our patient is ambulating independently, performing a straight leg raise and confident to return home with only mild discomfort. We look forward to monitoring her recovery through our research.”

The U-Propel study will enroll up to 200 patients. Patients will participate in baseline, pre-discharge, six-week, three, six and 12-month, as well as annual follow-up visits for up to five years. The study’s primary endpoint is implant survivorship. The secondary endpoints are Knee Society Score; radiographic success; subject satisfaction; KOOS, Jr.; EQ-5D and operative characteristics. The expected duration of the study is seven years.

“For more than two decades, our company has been engaged in helping orthopedic surgeons deliver high-quality care to their patients, providing them with innovative products designed to improve patient health and satisfaction,” said Calvin Lin, President of United Orthopedic Corporation USA. “The U-Propel study underscores our continued commitment to orthopedic care, building upon our foundation of research that demonstrates the value of our solutions.”

Outcomes from the U-Propel study will be analyzed and published in three phases as follows: after all enrolled patients have completed their six-week follow-up; at the two-year follow-up mark; and at the conclusion of the study. In addition to Dr. Cashen and the team of surgeons at Coastal Orthopedics, George Markovich, MD, is also an orthopedic surgeon and study investigator. Dr. Markovich is from the Institute for Orthopaedic Surgery and Sports Medicine in Fort Myers, Fla.

Osteoarthritis is a common disease of the aging demographic and a leading cause of disability, with the incidence of knee osteoarthritis rising with the increasing average age of the general population.1 Approximately 10 percent of people aged over 55 years have painful disabling knee osteoarthritis, of whom one quarter are severely disabled.1 TKA is one of the treatment options available to sufferers of knee osteoarthritis.

For more information about the U-Propel study, visit: https://clinicaltrials.gov/ct2/show/study/NCT03060057

UOC is actively recruiting qualified surgeons and their institutions who would like to participate in this post-market study. Please contact Mindy Carlson, Director of Clinical Research, at mindy.carlson@uocusa.com, or 612-562-0060, to inquire.

# # #

About United Orthopedic Corporation
United Orthopedic Corporation (UOC) is a leading international designer, manufacturer, and distributor of innovative, regulatory compliant orthopedic implants and instrument sets used by surgeons around the globe. UOC’s offering includes a flexible range of clinically proven solutions used to perform total hip/knee replacements and revisions, plus clinical education, service and support for surgeons and hospital staff. UOC operates Quality Management Systems (QMS) that comply with ISO 9001/13485, FDA, and CE requirements. For more information about United Orthopedic Corporation, visit www.uocusa.com.

Media Contact:
Tiffany Lin
tiffany.lin@uocusa.com
Tel: +1 949-328-3366

# # #

1 Heidari B. Knee osteoarthritis prevalence, risk factors, pathogenesis and features: Part I. Caspian Journal of Internal Medicine. 2011;2(2):205-212.

United Orthopedic Corporation Receives U.S. FDA Clearance for Company's Polyethylene Knee Insert

April 12, 2017

UNITED ORTHOPEDIC CORPORATION RECEIVES U.S. FDA CLEARANCE FOR COMPANY’S POLYETHYLENE KNEE INSERT

E-XPE™ Designed to Provide Wear Resistance With Reduced Risk of Oxidation

IRVINE, Calif., April 12, 2017 – United Orthopedic Corporation (UOC), a leading international designer, manufacturer and distributor of innovative orthopedic implants and instruments, today announced that the U.S. Food and Drug Administration (FDA) cleared its E-XPE™ polyethylene knee insert. The knee insert is designed to provide patients with knee replacements with reduced risk of oxidation.1

“Clearance of our E-XPE™ polyethylene knee insert represents an important milestone in our knee portfolio,” said Calvin Lin, President of United Orthopedic Corporation USA. “Oxidation continues to be a concern for surgeons. The E-XPE™ polyethylene is resistant to oxidation and performs extremely well with respect to abrasive wear resistance.”

The E-XPE™ is the new generation of highly cross-linked polyethylene blended with 0.1 percent (w/w) vitamin E to enhance wear resistance without compromising oxidative stability and mechanical properties.

UOC’s vertically integrated manufacturing process is unique, enabling the company to control the production cycle of their implants, from initial design to distribution in each of its manufacturing facilities. By doing so, UOC is capable of ensuring a stable, quality product supply and a remarkable level of customization to meet the needs of patients.

More than 600,000 knee replacements are performed each year in the United States.2

About United Orthopedic Corporation
United Orthopedic Corporation (UOC) is a leading international designer, manufacturer, and distributor of innovative, regulatory compliant orthopedic implants and instrument sets used by surgeons around the globe. UOC’s offering includes a flexible range of clinically proven solutions used to perform total hip/knee replacements and revisions, plus clinical education, service and support for surgeons and hospital staff. UOC operates Quality Management Systems (QMS) that comply with ISO 9001/13485, FDA, and CE requirements. For more information about United Orthopedic Corporation, visit www.uocusa.com.

Media Contact
Tiffany Lin
United Orthopedic Corporation
Tel: +1 949-328-3366
Email: Tiffany.Lin@uocusa.com

----------------------

1 Bellare, A. et al. Journal of Applied Polymer Science (2016). Oxidation Resistance and Abrasive Wear Resistance of Vitamin E Stabilized Radiation Crosslinked Ultra-High Molecular Weight Polyethylene, DOI:10.1002/APP.44125.
2 American Academy of Orthopedic Surgeons website. Beyond Surgery Day: The Full Impact of Knee Replacement. Accessed April 10, 2017 from: http://www.anationinmotion.org/value/knee.

United Orthopedic Corporation (UOC) Donates Orthopedic Replacement Systems to Hospital in China

July 5, 2016

United Orthopedic Corporation (UOC) Donates Orthopedic Replacement Systems to Hospital in China

Company Works With Atlanta-Area Surgeon to Provide Orthopedic Support to Underprivileged Community in Hefei

IRVINE, Calif., July 5, 2016 -- United Orthopedic Corporation (UOC), a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments, today announced the company has donated total hip and knee replacements to a hospital in Hefei China, 300 miles inland from Shanghai.

Freddy Achecar Jr., MD, medical director for the WellStar Douglas Hospital Center for Joint Replacement in Douglasville, Georgia, donated his services to help patients with limited income needing knee or hip replacement surgery.

“We were thrilled to have had the opportunity to give back to communities in need and work with a leading orthopedic surgeon,” said Calvin Lin, President of UOC USA, a subsidiary of UOC located in Irvine, CA. “There are villages, towns and cities in China located in remote areas, limiting patients’ and healthcare professionals’ access to optimal treatment. Working with Dr. Achecar to improve the lives of these patients has been wonderful.”

The donation was inspired by Dr. Achecar and his 17-year-old son Adam. As part of his Eagle Scout project, Adam wanted to incorporate his father’s work of restoring movement to patients who suffered from orthopedic conditions, and make treatment available to individuals who did not otherwise have access to such care.

Dr. Achecar liked his son’s idea and, as a result, reached out to his hospital’s supplier of orthopedic implants, UOC. UOC recommended that the doctor travel to the city of Hefei to help treat patients who had been historically underserved. UOC agreed to donate the necessary medical devices. The program was designed to provide patients with disabilities and the elderly, as well as low-income households, with joint replacement treatment they may otherwise not have had access to on their own.

Dr. Achecar spent a week performing seven joint replacements: five hip replacements and two knee replacements. His first patient was a 72-year old chicken farmer who had been bedridden as a result of his arthritis and needed a hip replacement. To his amazement, the very next day he felt no pain and went home to tell his wife. As a thank you, he returned to the hospital with a basket of eggs fresh from his farm, saying “this is our gift to you.”

“We are very grateful to be given this opportunity to make a real difference in the lives of these patients by helping them get the care they need for their joint pain,” said Dr. Achecar. “It has been an amazing journey and experience. We are thankful to UOC and their team for their commitment to patient care.”

UOC’s unique manufacturing process enables the company to control the production cycle of their implants, from initial design to distribution in each of its manufacturing facilities. By doing so, UOC is capable of ensuring the highest quality standards, a stable product supply, and a remarkable level of customization to meet the specific needs of each patient.

About United Orthopedic Corporation
United Orthopedic Corporation (UOC) is a leading international designer, manufacturer, and distributor of innovative, regulatory compliant orthopedic implants and instrument sets used by surgeons around the globe. UOC’s offering includes a flexible range of clinically proven solutions used to perform total hip/knee replacements and revisions, plus clinical education, service and support for surgeons and hospital staff. UOC operates Quality Management Systems (QMS) that comply with ISO 9001/13485, FDA, and CE requirements. For more information about United Orthopedic Corporation, visit www.uocusa.com.

Media Contact
Tiffany Lin
United Orthopedic Corporation
Tel: +1 949-328-3366
Email: Tiffany.Lin@uocusa.com

United Orthopedic Corporation Announces Enrollment of First U.S. Patient in Hip Replacement System Follow-Up Study

February 23, 2016

United Orthopedic Corporation Announces Enrollment of First U.S. Patient in
Hip Replacement System Follow-Up Study

Company Initiates U.S. Study of the Commercially Available U-Motion II+ Acetabular System and UTF Reduced Stem for Patients Who Require Primary Total Hip Arthroplasty

IRVINE, Calif., February 23, 2016 -- United Orthopedic Corporation (UOC), a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments, today announced the start of patient enrollment in a follow-up study in the U.S. of the commercially available U-Motion II+ Acetabular System and UTF Reduced Stem in patients receiving primary total hip arthroplasty (THA). The prospective, single arm, multi-center, post-approval study is designed to evaluate the short and long-term clinical performance of the devices, which are designed to improve hip flexion, reduce the risk of joint dislocation and allow for minimal bone removal during THA procedures.

“Despite numerous advances in hip replacement technology, issues such as postoperative dislocation, bearing wear and insufficient range of motion remain challenging problems, especially for younger, more active individuals,” said Kurtis Biggs, DO, founder of the Joint Replacement Institute in Naples, Florida. “The U-Motion II+ Acetabular System and UTF Reduced Stem are designed to address these issues by using enhanced implant materials, which allow for improved hip flexion and less risk of joint dislocation. We plan to investigate the clinical performance of the devices to further establish its benefit for patients seeking relief of hip pain or improved hip function.”

Dr. Biggs implanted the first U-Motion II+ Acetabular System and UTF Reduced Stem on a patient enrolled in the study on January 20, 2016 using the direct anterior approach, a minimally invasive, tissue-sparing technique that allows for quicker recovery and improved outcomes for patients. UOC plans to enroll up to 200 patients at a maximum of five sites in the U.S.

“This is an important milestone for United Orthopedic Corporation as we continue to establish our presence in the United States and provide life-changing technologies to address an unmet need in patients seeking a long-term solution for severe hip pain,” said Calvin Lin, President of UOC USA, a subsidiary of UOC located in Irvine, CA. “For over two decades, UOC has offered meaningful orthopedic solutions to practitioners and institutions that improve patient care.”

The primary objectives of the study include operative success, hip function at two-year follow up as measured by the Harris Hip Score (HHS) and device survivorship. Patients will be evaluated at predetermined intervals: baseline, procedure/discharge and six weeks, three months, six months, 12 months, and 24 months post treatment for primary analysis and annually up to five years for device survivorship. The estimated study duration from first enrollment through completion of the final report is expected to be approximately seven years.

The U-Motion II+ Acetabular System utilizes a unique coating technology intended to achieve a greater surface roughness of the implant. This allows for better initial stability and has been shown to reduce micromotion, both of which contribute to the long term fixation of the implant. , The UTF Reduced Stem, forged from titanium alloy, is a wedge-shaped stem that facilitates optimal placement and fit in femora of varying disphyseal and metaphyseal widths. It comes in 14 sizes, with standard and high offset options, and key sizes (ranging from 3 to 8) with 1mm increments. The stem features optimized neck geometry, which contributes to increased range of motion and decreased cup-neck impingement.

According to the Centers for Disease Control and Prevention’s National Center for Health Statistics, the number of total hip replacement surgeries among inpatients aged 45 and over more than doubled from 2000 to 2010, from 138,700 in 2000 to 310,800 in 2010.The percentage increase in the number of total hip replacements among inpatients aged 45 and over by age ranged from 92 percent for those 75 and over to 205 percent for those aged 45–54. UOC is dedicated to providing advanced solutions for joint treatment as the U.S. population ages and demand increases for improved technologies and procedures.

# # #

About United Orthopedic Corporation
United Orthopedic Corporation (UOC) is a leading international designer, manufacturer, and distributor of innovative, regulatory compliant orthopedic implants and instrument sets used by surgeons around the globe. Our offering includes a flexible range of clinically proven solutions used to perform total hip/knee replacements and revisions, plus clinical education, service and support for surgeons and hospital staff. UOC operates Quality Management Systems (QMS) that comply with ISO 9001/13485, FDA, and CE requirements. For more information about United Orthopedic Corporation, visit www.uocusa.com.

Media Contact:
Tiffany Lin
tiffany.lin@uocusa.com
Tel: +1 949-328-3366

  1. Moskal J, Capps S, Scanelli J. Anterior muscle sparing approach for total hip arthroplasty. World J Orthop. 2013 Jan 18; 4(1): 12–18. Published online 2013 Jan 18. doi: 10.5312/wjo.v4.i1.12
  2. Jasty M et al. In vivo skeletal responses to porous-surfaced implants subjected to small induced motions. J Bone Joint Surg Am. 1997 May;79(5):707-14.
  3. Feighan JE et al. The influence of surface-blasting on the incorporation of titanium-alloy implants in a rabbit intramedullary model. J Bone Joint Surg Am. 1995 Sep;77(9):1380-95.
  4. Wolford ML, Palso K, Bercovitz A. Hospitalization for total hip replacement among inpatients aged 45 and over: United States, 2000–2010. NCHS data brief, no 186. Hyattsville, MD: National Center for Health Statistics. 2015. Available from: http://www.cdc.gov/nchs/data/databriefs/db186.pdf.

United Orthopedic Corporation Enters U.S. Market

March 5, 2014

United Orthopedic Corporation Enters U.S. Market

International leader brings FDA-approved hip and knee replacement products to American orthopedic surgeons.

IRVINE, Calif.—Today, United Orthopedic Corporation (UOC) – a leading international designer, manufacturer, and distributor of innovative orthopedic implants and instruments – announced its entrance into the American market, offering clinically proven, safe and cost-effective hip and knee devices through its U.S. subsidiary, UOC USA.

“United Orthopedic Corporation is the first Asian orthopedic company to receive FDA approval for join reconstruction,” said Calvin Lin, president of UOC USA. “For the past 20 years we’ve been recognized for our innovative products and we are excited to bring our high-performing line of hip and knee replacement systems to American orthopedic surgeons.”

Established in 1993 and headquartered in Taiwan, UOC has been supplying and supporting orthopedic practitioners and institutions around the world with arthroplasty implant and instrument designs created by its vertically integrated, in-house manufacturing team. Its innovative designs are based on firsthand practitioner input, as well as rigorous clinical research, and are known for meeting world quality assurance standards. UOC products are currently selling in 22 countries worldwide and been used in more than 160,000 cases to date.

 “I’ve been using the U2 Knee™ System from UOC for seven years and believe the design and quality of UOC’s products can help to improve the lives of arthroplasty patients all around the world,”, said Thomas Ferro, M.D., an orthopedic surgeon and medical director at the Bone and Joint Center in Arroyo Grande, Calif. “In addition to quality joint replacement systems with great range of motion, UOC also offers surgeon-friendly instrument design which saves time on the operating table. Results from an outstanding seven-year clinical study will be presented at the ICJR Pan Pacific Congress this summer.”

“Because our manufacturing process is vertically integrated,” continued Lin, “we are able to oversee every aspect of our products’ manufacturing – from the initial design to packaging the finished product. This integration allows us to offer outstanding quality and provide incredibly responsive service.”

According to the Centers for Disease Control and Prevention (CDC), 332,000 hip and 719,000 knee replacements are performed in the United States each year in order to increase mobility, improve the function of the joint, and relieve pain.

# # #

About United Orthopedic Corporation
United Orthopedic Corporation (UOC) is a leading international designer, manufacturer, and distributor of innovative, regulatory compliant orthopedic implants and instrument sets used by surgeons around the globe. Our offering includes a flexible range of clinically proven solutions used to perform total hip/knee replacements and revisions, plus clinical education, service and support for surgeons and hospital staff. UOC operates Quality Management Systems (QMS) that comply with ISO 9001/13485, FDA, and CE requirements. For more information about United Orthopedic Corporation, visit www.uocusa.com.

Media Contact:
Tiffany Lin
tiffany.lin@uocusa.com
Tel: +1 949-328-3366